News & Media
November 28, 2006
Omega Protein Closes Purchase of 36.5% of it's Outstanding Common Stock from Zapata Corporation
HOUSTON, November 28, 2006 – Omega Protein Corporation (NYSE symbol: OME), the nation's leading producer of Omega-3 fish oil and specialty fish meal products, today announced that it has closed its previously announced transaction with Zapata Corporation (NYSE symbol: ZAP), to purchase from Zapata 9,268,292 shares of Omega's common stock at a purchase price of $5.125 per share. The aggregate purchase price for the shares, which represent 36.5% of Omega's outstanding common stock, was $47.5 million. In connection with the closing, Zapata's two representatives, Avram A. Glazer and Leonard DiSalvo, have resigned from Omega's Board of Directors.
Omega financed the purchase of the 9,268,292 shares with a previously disclosed senior secured financing facility from Abelco Finance LLC, an affiliate of Cerberus Capital Management, L.P. The facility provides for a five-year, $35 million term loan and a five-year, $30 million revolving credit facility.
If Zapata still owns any shares of Omega's common stock nine months after the closing of the transaction, Omega has the option for a four-month period thereafter to purchase any remaining Omega shares held by Zapata at a purchase price of $4.50 per share.
The transaction was unanimously approved by a Special Committee of Omega directors who are independent of Zapata. TM Capital Corp. has acted as financial advisor to the Special Committee, and has delivered requested opinions with respect to the transaction to the Special Committee.
Joe von Rosenberg, President and Chief Executive Officer of Omega, commented: "We believe that the terms of the transaction are highly favorable to our stockholders and we anticipate that the transaction should be accretive to earnings per share in the future. Also, this transaction has allowed Zapata to substantially reduce its ownership position in an orderly fashion."
About Omega Protein
Omega Protein Corporation is the nation's largest manufacturer of heart-healthy fish oils containing Omega-3
fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients
in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3
rich fish that is not utilized as seafood, but which is abundantly available along the U.S. Gulf of Mexico
and Atlantic Coasts.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: The statements contained in this press release that are not
historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual
results of future events described in any of these forward-looking statements could differ materially from
those stated in the forwardlooking statements. Important factors that could cause actual results to be materially
different from those forward-looking statements include, among others: (1) the Company's ability to meet its
raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural
conditions over which the Company has no control, such as varying fish population, fish oil yields, adverse
weather conditions and disease; (2) the impact of worldwide supply and demand relationships on prices for
the Company's products; (3) Omega Protein's expectations regarding demand for OmegaPure® proving to be
incorrect; and (4) fluctuations in the Company's quarterly operating results due to the seasonality of
the Company's business and its deferral of inventory sales based on worldwide prices for competing products.
These and other factors are described in further detail in Omega's filings with the Securities and Exchange
Commission, including its 2006 Annual Report on Form 10K under the headings, "Management's Discussion and
Analysis of Financial Condition" and "Risk Factors."